Elizabeth Mily
Fortune : 769 729 $ au 31/07/2026
Fortune : 769 729 $ au 31/07/2026
Elizabeth Mily est vice-présidente exécutive chargée de la stratégie et du développement commercial chez Bristol Myers Squibb Co. Auparavant, Mme Mily a occupé les postes de directrice de la stratégie et du développement de l'entreprise chez Thermo Fisher Scientific, Inc. et de directrice générale chez Goldman Sachs & Co. LLC et membre senior du Global Healthcare Group chez Barclays US LLC. Elle a obtenu un diplôme d'études supérieures de l'université de Georgetown et un diplôme de premier cycle de l'université d'État de l'Ohio.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,01 % | 15/05/2026 | 9 009 ( 0,01 % ) | 769 729 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
JDRF T1D Fund LLC
JDRF T1D Fund LLC Investment ManagersFinance Acts as Venture Capital Fund | Directeur Général | 08/01/2024 |
Ampersand Biomedicines
Ampersand Biomedicines BiotechnologyHealth Technology Develops and manufactures medicines | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance T1D Fund invests in companies located across the globe. The firm focuses on health technology sector. It participates in early stage capital requirements. | Directeur Général | 01/06/2026 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2024 |
| BARCLAYS PLC | Corporate Officer/Principal | 01/01/2020 |
| C.R. BARD | President | 01/01/2017 |
| THERMO FISHER SCIENTIFIC, INC. | Corporate Officer/Principal | 01/01/2010 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 14 |
|---|---|
C. R. Bard, Inc. (New Jersey)
C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology Designs, manufactures, packages, distributes and sells medical, surgical, diagnostic & patient care devices | Health Technology |
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
The Goldman Sachs Group, Inc.
The Goldman Sachs Group, Inc. Investment Banks/BrokersFinance Provides investment banking, asset, wealth management and platform services | Finance |
MyoKardia, Inc.
MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Barclays PLC
Barclays PLC Investment Banks/BrokersFinance Operates as a bank holding company whose subsidiaries engages in retail banking, credit cards, corporate and investment banking and wealth management services | Finance |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Barclays US LLC
Barclays US LLC Regional BanksFinance Operates as a bank holding company whose subsidiaries provides banking services | Finance |
JDRF T1D Fund LLC
JDRF T1D Fund LLC Investment ManagersFinance Acts as Venture Capital Fund | Finance |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance T1D Fund invests in companies located across the globe. The firm focuses on health technology sector. It participates in early stage capital requirements. | Finance |
Stephen Gaynor School
Stephen Gaynor School Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit pre-K school | Commercial Services |
Ampersand Biomedicines
Ampersand Biomedicines BiotechnologyHealth Technology Develops and manufactures medicines | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national